Trajectories and Predictors for the Development of Clinically Significant Weight Gain in Children and Adolescents Prescribed Second-Generation Antipsychotics-Reference-Cited by-同舟云学术

Trajectories and Predictors for the Development of Clinically Significant Weight Gain in Children and Adolescents Prescribed Second-Generation Antipsychotics

Published:2024-05-01 Issue:4 Volume:34 Page:201-209
ISSN:1044-5463
Container-title:Journal of Child and Adolescent Psychopharmacology
language:en
Short-container-title:Journal of Child and Adolescent Psychopharmacology

Author:

Lyu Ning¹^ORCID,Rowan Paul J.²,Abughosh Susan¹,Varisco Tyler J.¹,Lin Ying³,Chen Hua¹^ORCID

Affiliation:

1. Department of Pharmaceutical Health Outcomes and Policy, College of Pharmacy, University of Houston, Houston, Texas, USA.

2. School of Public Health, The University of Texas at Houston, Houston, Texas, USA.

3. College of Engineering, University of Houston, Houston, Texas, USA.

Publisher

Mary Ann Liebert Inc

Link

https://www.liebertpub.com/doi/pdf/10.1089/cap.2023.0071

Reference29 articles.

1. Weight Gain and Metabolic Abnormalities During Extended Risperidone Treatment in Children and Adolescents

2. Endocrine and Metabolic Adverse Effects of Psychotropic Medications in Children and Adolescents

3. Risk factors and pattern of weight gain in youths using antipsychotic drugs

4. Group-based Trajectory Models

5. Association Between Second-Generation Antipsychotics and Changes in Body Mass Index in Adolescents

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From the Editor-in-Chief’s Desk: Are Omega-3 Fatty Acid Supplements an Effective, Safe, and Scalable Treatment for Depression in Children and Adolescents?;Journal of Child and Adolescent Psychopharmacology;2024-08-21

2. From the Editor-in-Chief’s Desk: Advancing Evidence-Based Treatments for Disruptive Mood Dysregulation Disorder;Journal of Child and Adolescent Psychopharmacology;2024-06-01

3. From the Editor-in-Chief’s Desk: Precision Classification and Treatment of Early Life Mood Disorders for Improved Outcomes;Journal of Child and Adolescent Psychopharmacology;2024-05-01